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Identity 
Location : 19q13.4 
DNA/RNA 
Transcription 
5.5 kB mRNA. 
Protein 
Expression 






t(19;21)(q13.4;q22) with AML1 
involvement 
Disease 
Acute non lymphocytic leukemia (ANLL) secondary to 
toxic exposure. 
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